Amgen CEO says will not raise drug prices again this year
Amgen Inc Chief Executive Robert Bradway said on Thursday that the biotechnology company will not raise drug prices for the remainder of the year.
Amazon beats estimates, and Wall St. breathes a sigh
Wall Street breathed a sigh of relief on Thursday after Amazon.com’s quarterly results beat estimates, sending the online retailer’s stock higher and alleviating fears of deepening troubles across the FANG group after Facebook’s results sent its shares…
Chesapeake Energy plans to sell Utica shale stake for $2 billion
Chesapeake Energy Corp plans to sell all of its Ohio natural gas acreage to privately owned Encino Acquisition Partners for about $2 billion, the company said on Thursday.
SEC says it will not approve Winklevoss bitcoin ETF
The U.S. Securities and Exchange Commission on Thursday said it would reaffirm an earlier decision not to let a proposed bitcoin-tracking exchange-traded fund trade.
Starbucks reports cooling quarterly growth and pares outlook
Starbucks Corp forecast slower growth for the current fiscal year on Thursday as boutique coffee chains and fast-food retailers won business in the United States and other established markets and the bloom came off once-booming China.
Zuckerberg loses more than $15 billion in record Facebook fall
Facebook Inc Chief Executive Mark Zuckerberg’s fortune took a more than $15 billion hit on Thursday, as the social media company suffered the biggest one-day wipeout in U.S. stock market history a day after executives forecast years of lower profit ma…
Amazon earnings skyrocket on cloud computing, advertising
Amazon.com Inc forecast strong fall sales and posted a profit that was double Wall Street targets on Thursday thanks to the retailer’s younger, higher-earning businesses, including cloud computing and advertising.
Fonterra Chairman resigns on health concerns
Milk producer Fonterra said on Friday Chairman John Wilson has resigned from his position with immediate effect over concerns regarding his health.
Amgen quarterly profit beats Wall Street view on new product sales
Amgen Inc on Thursday reported a better-than-expected second quarter profit and raised its full-year forecast, as growth of newer drugs like cholesterol fighter Repatha and osteoporosis drug Prolia offset weakness in older products.
Intel’s data center business misses estimates, shares fall
Intel Corp missed analysts’ estimates for its closely watched data center business on Thursday as it faced stiff competition from rival Advanced Micro Devices Inc , sending its shares down 3 percent in extended trading.
